![]() |
市場調查報告書
商品編碼
1500567
輸尿管鏡市場:按類型、目的、應用、最終用戶分類 - 全球預測 2024-2030Ureteroscope Market by Type (Flexible Ureteroscopes, Rigid Ureteroscopes, Semirigid Ureteroscopes), Usage (Multi-Use, Single-Use/Disposable), Application, End User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年輸尿管鏡市場規模為11億美元,預計2024年將達11.6億美元,2030年將達16.4億美元,複合年成長率為5.77%。
輸尿管鏡是一種細長的管狀醫療器械,具有照明和影像處理功能,設計用於輸尿管的診斷和治療檢查,輸尿管將尿液從腎臟輸送到膀胱。這種專用的內視鏡小心地插入尿道,穿過膀胱,最後插入輸尿管。其主要功能包括腎結石、輸尿管狹窄和腫瘤等輸尿管疾病的識別和治療。輸尿管鏡檢查對於促進微創手術至關重要,可以在輸尿管內進行直接可視化、切片檢查和治療,而無需大範圍的手術切口。日益成長的老年人口(更容易患泌尿器官系統疾病)以及全球腎結石發病率的增加正在推動輸尿管鏡檢查的需求。然而,先進輸尿管鏡的高成本限制了它們的承受能力和採用,特別是在成本敏感的市場。然而,開拓具有卓越視覺化功能(包括 3D 影像和擴增實境引導)的輸尿管鏡以提高手術精度可能代表著市場成長的機會。
主要市場統計 | |
---|---|
基準年[2023] | 11億美元 |
預測年份 [2024] | 11.6億美元 |
預測年份 [2030] | 16.4億美元 |
複合年成長率(%) | 5.77% |
區域洞察
由於尿道結石和其他泌尿系統疾病的盛行率不斷增加,美洲輸尿管鏡市場的特徵是對輸尿管軟鏡和硬性輸尿管鏡的需求量很大。美國因其強大的醫療基礎設施、先進技術和高昂的醫療費用而領先市場規模。此外,該地區還有許多主要製造商,增加了獲得最新輸尿管鏡型號的機會。政府透過採用基於價值的採購模式來減少醫療保健支出,這推動了對具有成本效益的高品質輸尿管鏡的需求。歐洲、中東和非洲地區為輸尿管鏡提供了多樣化的市場環境,在先進的醫療保健系統和強勁的醫療保健支出的推動下,歐洲在市場採用率方面處於領先地位,尤其是在德國、法國和英國等國。另一方面,中東和非洲市場仍在發展中,成長受到醫療基礎設施有限和醫療費用低廉的限制。也就是說,中東醫療保健提供者對採用更新的輸尿管鏡技術的興趣很大,這表明潛在的市場成長潛力。歐洲的監管政策和醫療改革也影響先進輸尿管鏡設備的引進,重點在於病人安全和成本效率。在中國、印度和日本等國家醫療基礎設施的快速發展和醫療成本不斷上升的推動下,亞太地區的輸尿管鏡檢查呈現出有利的情況。該地區的腎結石和其他泌尿系統疾病正在迅速增加,這推動了對輸尿管鏡的需求。然而,該地區一些經濟體的成本敏感性也反映了對負擔得起的醫療設備的需求。因此,隨著全球和區域製造商專注於開發具有成本效益且技術先進的輸尿管鏡以滿足不斷變化的醫療保健需求,競爭格局正在改變。
FPNV定位矩陣
FPNV定位矩陣對於評估供應商在輸尿管鏡市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢查了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對輸尿管鏡市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他關鍵指標。此外,該分析還提供了對該行業競爭性質的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對輸尿管鏡市場目前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[180 Pages Report] The Ureteroscope Market size was estimated at USD 1.10 billion in 2023 and expected to reach USD 1.16 billion in 2024, at a CAGR 5.77% to reach USD 1.64 billion by 2030.
A ureteroscope is a thin, tube-like medical instrument equipped with lighting and imaging capabilities, designed for the diagnostic and therapeutic examination of the ureter for conveying urine from the kidney to the bladder. This specialized scope is carefully inserted into the urethra, navigated through the bladder, and eventually into the ureter. Its primary functions include the identification and management of ureteral conditions such as kidney stones, ureteral strictures, and tumors. Ureteroscopes are pivotal in facilitating minimally invasive procedures, allowing for direct visualization, biopsy, and treatment within the urinary tract without the need for extensive surgical incisions. An increasing elderly population prone to urological conditions coupled with a growing incidence of kidney stones worldwide drives demand for ureteroscopy procedures. However, the high cost of advanced ureteroscopes limits their affordability and adoption, particularly in cost-sensitive markets. Nevertheless, developing ureteroscopes with superior visualization capabilities, including 3-D imaging and augmented reality guidance, to improve procedural accuracy may provide an opportunistic landscape for market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 1.10 billion |
Estimated Year [2024] | USD 1.16 billion |
Forecast Year [2030] | USD 1.64 billion |
CAGR (%) | 5.77% |
Regional Insights
The ureteroscope market in the Americas is characterized by high demand for both flexible and rigid ureteroscopes, spurred by a growing prevalence of urolithiasis and other urological conditions. The United States leads in terms of market size, attributed to strong healthcare infrastructure, availability of advanced technology, and significant health expenditure. Moreover, the region hosts numerous key manufacturers, enhancing access to the latest ureteroscope models. Government initiatives aimed at reducing healthcare expenditure through the adoption of value-based procurement models are driving demand for cost-effective and high-quality ureteroscopes. The EMEA region shows a diverse market landscape for ureteroscopes, with Europe leading in terms of market adoption rates, driven by advanced healthcare systems and robust healthcare spending, particularly in countries including Germany, France, and the UK. The market in the Middle East and Africa, however, is still developing, with growth restrained by limited healthcare infrastructure and lower healthcare expenditure. Nevertheless, there's a notable interest in adopting newer ureteroscopic technologies among healthcare providers in the Middle East, indicating potential market growth. Regulatory policies and healthcare reforms across Europe are also influencing the uptake of advanced ureteroscopic devices, focusing on patient safety and cost-efficiency. The Asia Pacific region shows an opportunistic landscape for ureteroscopes, driven by rapid healthcare infrastructure advancements and increasing healthcare expenditure in countries such as China, India, and Japan. The region is witnessing a surge in the prevalence of kidney stones and other urological conditions, which in turn is propelling the demand for ureteroscopes. However, the market is also characterized by a demand for affordable medical devices, given the cost-sensitive nature of several economies within the region. This has led to a competitive landscape where both global and regional manufacturers are focusing on developing cost-effective and technologically advanced ureteroscopes to cater to evolving healthcare needs.
Market Insights
The market dynamics represent an ever-changing landscape of the Ureteroscope Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Ureteroscope Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Ureteroscope Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Ambu receives European approval for ureteroscopy products
Ambu has received European regulatory approval for its ureteroscopy solution, supporting its expansion within the realm of urology procedures. This revolutionary product comprises the Ambu aScope 5 Uretero, a flexible, single-use ureteroscope crafted from eco-friendly Bio-ABS material, alongside the Ambu aBox 2, an advanced full-HD endoscopy system. The device aims to cater to the growing demand for single-use endoscopic solutions, providing high-quality imaging, durability, and maneuverability essential for addressing kidney and ureteral stones, ureteral strictures, and urothelial cancers. [Published On: 2023-11-29]
Capstone team enhances safety of ureteroscopy procedure
A recent initiative from Texas A&M University, called Infection Detection, has led to the development of a pioneering device aimed at early detection of urinary tract infections (UTIs) in patients undergoing ureteroscopy surgeries. This effort is sponsored by the medical technology firm Becton Dickinson (BD), which integrates seamlessly with current ureteroscopy procedures. This advances the diagnostic process significantly, reducing the standard detection time from days to potentially hours with further optimization. [Published On: 2023-07-20]
Boston Scientific Receives FDA Clearance for LithoVue Elite Single-Use Digital Flexible Ureteroscope System
Boston Scientific Corporation has received U.S. FDA 510(k) clearance for its innovative LithoVue Elite Single-Use Digital Flexible Ureteroscope System. This system stands out as the first ureteroscope equipped with a breakthrough feature allowing the real-time monitoring of intrarenal pressure during ureteroscopy procedures, a common but critical operation used in diagnosing and treating urinary tract issues, particularly kidney stones. With the integration of a built-in pressure sensor, the LithoVue Elite enables urologists to make immediate and informed decisions based on pressure changes, thus enhancing patient care by potentially reducing the likelihood of post-operative complications like systemic inflammatory response syndrome (SIRS), sepsis, and renal damage. [Published On: 2023-02-03]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Ureteroscope Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Ureteroscope Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Becton, Dickinson and Company, Biomerics, Boston Scientific Corporation, Dornier MedTech GmbH, E.M.S. Electro Medical Systems S.A., Elmed Medical Systems, ERBE Elektromedizin GmbH, Karl Storz Medical AG, Obex, Olympus Corporation, OPCOM, OTU Medical Inc., PENTAX Medical, Prosurg Inc., Richard Wolf GmbH, Rocamed, SCHOLLY FIBEROPTIC GMBH, Stryker Corporation, and Vimex Sp. z o.o.
Market Segmentation & Coverage